Σύγκριση μεθόδων

	Κλίμακα Αυτο-αποτελεσματικότητας για την Κατανόηση και Χρήση Φαρμάκων (MUSE-S)	Ερωτηματολόγιο Ικανοποίησης Θεραπείας για Φαρμακευτική Αγωγή (TSQM)
Πεδίο	Φαρμακολογία	Φαρμακολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2009	2004
Δημιουργός	Sunil Kripalani, Jill Risser, Monica E. Gatti, and Thomas A. Jacobson	Mary Jo Atkinson and colleagues
Τύπος	Self-report	Self-report
Θεμελιώδης πηγή	Kripalani, S., Risser, J., Gatti, M. E., & Jacobson, T. A. (2009). Development and validation of a simple questionnaire to measure medication understanding. Medical Care, 47(3), 340-348.	Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Berman, B. M., & Wolpert, B. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel of chronically ill individuals. Health and Quality of Life Outcomes, 2(1), 12.
Εναλλακτικές ονομασίες	MUSE-S	TSQM
Συναφείς	4	4
Σύνοψη	The Medication Understanding and Use Self-Efficacy Scale (MUSE-S) is a brief, patient-centered self-report measure assessing both knowledge and confidence regarding medication use. Developed by Kripalani and colleagues at Emory University in 2009, the MUSE-S evaluates whether patients understand their medications (what they are for, how to take them, important side effects) and feel confident managing them in daily life. This dual focus on knowledge and self-efficacy makes the MUSE-S particularly valuable for identifying education gaps, assessing health literacy barriers to medication adherence, and evaluating outcomes of medication counseling or education interventions.	The Treatment Satisfaction Questionnaire for Medication (TSQM) is a 14-item generic measure developed by Atkinson and colleagues in 2004 to assess patient satisfaction with medication across diverse therapeutic areas and disease conditions. It measures four key dimensions—Effectiveness, Side Effects, Convenience, and Global Satisfaction—with standardized 0–100 scoring, making it suitable for cross-disease comparison and health economic evaluation. The TSQM has become a standard outcome in pharmaceutical research, clinical trials, and real-world medication effectiveness studies.